Article Details

GSK and Medicago's COVID-19 vaccine shows promising antibody responses in phase 2

Retrieved on: 2021-05-19 11:26:15

Tags for this article:

Click the tags to see associated articles and topics

GSK and Medicago's COVID-19 vaccine shows promising antibody responses in phase 2. View article details on hiswai:

Excerpt

After two doses, the adjuvanted vaccine candidate induced robust neutralising antibody and cellular immune responses in all subjects, irrespectively ...

Article found on: www.pmlive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up